CHRONIC MIGRAINE
Clinical trials for CHRONIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MIGRAINE trials appear
Sign up with your email to follow new studies for CHRONIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device zaps migraines? tiny study tests safety
Disease control OngoingThis early study tests a new device called PRIMUS that uses mild electrical pulses to stimulate nerves in the head and face for people with chronic migraine. The main goal is to check if the device is safe to use. Only 7 people took part, and the study is not yet recruiting.
Matched conditions: CHRONIC MIGRAINE
Phase: NA • Sponsor: Salvia BioElectronics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for teens with chronic migraines?
Disease control OngoingThis study tests whether galcanezumab, a monthly injection, can prevent migraines in teens aged 12 to 17 with chronic migraine (15+ headache days per month). About 312 participants will receive either the drug or a placebo for 3 months. The goal is to see if the drug safely reduc…
Matched conditions: CHRONIC MIGRAINE
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New shot could stop chronic migraines before they start
Prevention OngoingThis study tests whether Dysport injections can prevent chronic migraine in adults who have headaches at least 15 days per month. About 759 participants will receive either Dysport or a placebo injection into head, neck, and shoulder muscles. The goal is to see if Dysport reduces…
Matched conditions: CHRONIC MIGRAINE
Phase: PHASE3 • Sponsor: Ipsen • Aim: Prevention
Last updated May 17, 2026 02:43 UTC
-
New study: simple behavior changes may ease chronic migraine burden
Symptom relief OngoingThis study tests whether brief behavioral programs can reduce disability and symptoms in adults with chronic migraine. 300 participants will be randomly assigned to one of four remote interventions. The goal is to see if changing behaviors can improve daily life and reduce migrai…
Matched conditions: CHRONIC MIGRAINE
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated May 17, 2026 02:43 UTC
-
New hope for migraine sufferers: atogepant under Real-World study
Symptom relief OngoingThis study looks at how well the drug atogepant works to prevent migraines in everyday life. About 500 adults with migraine (with or without aura) will take atogepant and report their migraine days over a year. The goal is to see if it reduces migraine frequency and is safe and t…
Matched conditions: CHRONIC MIGRAINE
Sponsor: University of Florence • Aim: Symptom relief
Last updated May 12, 2026 13:39 UTC